SCHEMBL19252636

SCHEMBL19252636

C=CNC(/N=C\N)=C(\C)C(=C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24697309 0.85
SCHEMBL22787179 0.81
SCHEMBL13190771 0.80
SCHEMBL24322914 0.70 ALDH1A1 (0.30)
SCHEMBL12677130 0.67
SCHEMBL18520404 0.67
SCHEMBL18519850 0.64
SCHEMBL19662459 0.64
SCHEMBL18520405 0.63
SCHEMBL19252676 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200392503-A1 METHODS AND COMPOSITIONS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE Regulus Therapeutics Inc. (US) 2020-12-17 US disclosed
WO-2017133655-A1 BENZOTHIAZINE AND BENZOTHIADIAZINE COMPOUNDS AND PREPARATION AND USE 浙江大学 2017-08-10 WO disclosed